Biography and Research Information
OverviewAI-generated summary
Benjamin J. Lieblong's research focuses on the therapeutic treatment of cervical intraepithelial neoplasia (CIN). He has been involved in clinical trials investigating the efficacy of peptide-based human papillomavirus (HPV) therapeutic vaccines, such as PepCan, often in combination with adjuvants like Candida. His work includes evaluating treatment outcomes for CIN2/3 lesions, with a focus on immune responses, including the expansion of HPV-specific T cells. Lieblong has also contributed to studies examining cardiac inflammation following local irradiation, exploring its relationship with the kallikrein-kinin system. His scholarship metrics include an h-index of 10 with 25 publications and 408 citations. He has collaborated extensively with researchers at the University of Arkansas for Medical Sciences, including Martin Hauer-Jensen and Vijayalakshmi Sridharan, with whom he shares multiple publications.
Metrics
- h-index: 10
- Publications: 25
- Citations: 411
Selected Publications
-
A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025)
-
A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023)
-
Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed (2021)
Collaboration Network
Top Collaborators
Vijayalakshmi Sridharan
8 shared publications
In database
- Supplementary Data 1-6 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
Showing 5 of 8 shared publications
Preeti Tripathi
8 shared publications
- Supplementary Data 1-6 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
Showing 5 of 8 shared publications
Eduardo G. Moros
8 shared publications
- Supplementary Data 1-6 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
Showing 5 of 8 shared publications
Peter M. Corry
8 shared publications
- Supplementary Data 1-6 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
Showing 5 of 8 shared publications
Elena Kaschina
8 shared publications
- Supplementary Data 1-6 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
Showing 5 of 8 shared publications
Christa Thöne‐Reineke
8 shared publications
- Supplementary Data 1-6 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
Showing 5 of 8 shared publications
Martin Hauer‐Jensen
8 shared publications
In database
- Supplementary Data 1-6 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
Showing 5 of 8 shared publications
Marjan Boerma
8 shared publications
In database
- Supplementary Data 1-6 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
Showing 5 of 8 shared publications
Thomas A. Unger
6 shared publications
- Supplementary Data 1-6 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 8 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
- Supplementary Figure 7 from Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
Showing 5 of 6 shared publications
Takeo Shibata
University of Arkansas for Medical Sciences
3 shared publications
In database
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i>
Sumit K. Shah
University of Arkansas for Medical Sciences
3 shared publications
In database
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i>
Teresa Evans
University of Arkansas for Medical Sciences
3 shared publications
In database
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i>
Hannah Coleman
University of Arkansas for Medical Sciences
3 shared publications
In database
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i>
Charles M. Quick
University of Arkansas for Medical Sciences
3 shared publications
In database
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i>
Yong‐Chen Lu
University of Arkansas for Medical Sciences
3 shared publications
In database
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i>
Similar Researchers
Based on overlapping research topics
Keanna Marsh
University of Arkansas for Medical Sciences
Cervical Cancer and HPV Research
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Cordell Gilreath
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Disease Mechanisms Research
Haley Kelly
University of Arkansas for Medical Sciences
Cervical Cancer and HPV Research
Cancer Treatment and Pharmacology
Disease Mechanisms Research
T Wonder NO Meridia
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Disease Mechanisms Research
Samuel L. Schach
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Disease Mechanisms Research
D Heinrichs
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Disease Mechanisms Research